You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
4 March 2015Clinical trials in near infrared fluorescence imaging with IRDye 800CW
A monofunctional, heptamethine dye, IRDye® 800CW, is being manufactured under GMP conditions for use in human clinical trials. When attached to a suitable targeting agent and paired with an appropriate camera system, the dye allows Near Infrared (NIR) fluorescence imaging of tumor tissue during surgery. The talk will describe the properties of the dye and give an overview of current and planned clinical trials in Europe and the USA. The dye is available in both the NHS ester and carboxylate forms for conjugation to targeting molecules. A GMP toxicology study of the dye was described in a previous publication.
Daniel R. Draney
"Clinical trials in near infrared fluorescence imaging with IRDye 800CW", Proc. SPIE 9311, Molecular-Guided Surgery: Molecules, Devices, and Applications, 93110L (4 March 2015); https://doi.org/10.1117/12.2079285
The alert did not successfully save. Please try again later.
Daniel R. Draney, "Clinical trials in near infrared fluorescence imaging with IRDye 800CW," Proc. SPIE 9311, Molecular-Guided Surgery: Molecules, Devices, and Applications, 93110L (4 March 2015); https://doi.org/10.1117/12.2079285